Guardion Health Sciences, Inc. financial data

Symbol
GHSI on Nasdaq
Industry
Pharmaceutical Preparations
Location
2925 Richmond Avenue, Suite 1200, Houston, TX
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Guardion Health Sciences, LLC (to 5/18/2015)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.02K % +50.5%
Quick Ratio 96.4 % -10.2%
Debt-to-equity 53 % -14%
Return On Equity 77.2 %
Return On Assets 50.5 %
Operating Margin -36.4 % +80.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.28M shares +0.85%
Common Stock, Shares, Outstanding 1.28M shares +1.33%
Entity Public Float 9.9M USD +7.61%
Common Stock, Value, Issued 1.28K USD +1.34%
Weighted Average Number of Shares Outstanding, Basic 1.28M shares +1.33%
Weighted Average Number of Shares Outstanding, Diluted 1.3M shares +2.33%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 12.1M USD +39.3%
Research and Development Expense 91.1K USD -63.5%
Selling and Marketing Expense 1.47M USD -9.3%
General and Administrative Expense 7.26M USD -1.82%
Operating Income (Loss) -4.39M USD +72.5%
Nonoperating Income (Expense) -1.29M USD -178%
Net Income (Loss) Attributable to Parent 6.37M USD
Earnings Per Share, Basic 4.96 USD/shares
Earnings Per Share, Diluted 4.87 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.8M USD +77.2%
Cash, Cash Equivalents, and Short-term Investments 12.9M USD +22.6%
Accounts Receivable, after Allowance for Credit Loss, Current 12.7K USD -99.2%
Inventory, Net 77.8K USD -96.9%
Assets, Current 15.3M USD +13.9%
Property, Plant and Equipment, Net 6.65K USD -84.5%
Operating Lease, Right-of-Use Asset 24.3K USD 0%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Assets 15.3M USD +13.5%
Accounts Payable, Current 113K USD -88.5%
Accrued Liabilities, Current 797K USD +76%
Liabilities, Current 917K USD -54.1%
Liabilities 1.55M USD -75.2%
Retained Earnings (Accumulated Deficit) -88M USD +6.76%
Stockholders' Equity Attributable to Parent 13.8M USD +89.9%
Liabilities and Equity 15.3M USD +13.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -755K USD +59.8%
Net Cash Provided by (Used in) Financing Activities -5.25M USD -153%
Net Cash Provided by (Used in) Investing Activities -1.65K USD +100%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 1.28M shares +1.33%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -755K USD +89.4%
Deferred Tax Assets, Valuation Allowance 17M USD +2.58%
Operating Lease, Liability 3.81K USD -85%
Depreciation 58.8K USD -35.8%
Payments to Acquire Property, Plant, and Equipment 1.65K USD -31.2%
Lessee, Operating Lease, Liability, to be Paid 3.83K USD -85.7%
Property, Plant and Equipment, Gross 180K USD +2.15%
Operating Lease, Liability, Current 3.81K USD -82.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.83K USD -83.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19 USD -97%
Deferred Tax Assets, Operating Loss Carryforwards 11.8M USD +11.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 3K USD
Additional Paid in Capital 102M USD +0.13%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.19M USD
Deferred Tax Assets, Net of Valuation Allowance 1.39M USD +172%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%